PL310896A1 - Cyclic compounds useful as platelet iib/iiia glycoprotein inhibitors - Google Patents
Cyclic compounds useful as platelet iib/iiia glycoprotein inhibitorsInfo
- Publication number
- PL310896A1 PL310896A1 PL94310896A PL31089694A PL310896A1 PL 310896 A1 PL310896 A1 PL 310896A1 PL 94310896 A PL94310896 A PL 94310896A PL 31089694 A PL31089694 A PL 31089694A PL 310896 A1 PL310896 A1 PL 310896A1
- Authority
- PL
- Poland
- Prior art keywords
- compounds useful
- cyclic compounds
- glycoprotein inhibitors
- platelet iib
- iiia glycoprotein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3844893A | 1993-03-29 | 1993-03-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL310896A1 true PL310896A1 (en) | 1996-01-08 |
Family
ID=21900014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL94310896A PL310896A1 (en) | 1993-03-29 | 1994-03-28 | Cyclic compounds useful as platelet iib/iiia glycoprotein inhibitors |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0691987A1 (en) |
| JP (1) | JPH08508498A (en) |
| AU (1) | AU6415894A (en) |
| CA (1) | CA2159070A1 (en) |
| FI (1) | FI954556A0 (en) |
| HU (1) | HUT72896A (en) |
| NO (1) | NO953832L (en) |
| NZ (1) | NZ263456A (en) |
| PL (1) | PL310896A1 (en) |
| WO (1) | WO1994022910A1 (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2126748T3 (en) * | 1993-03-29 | 1999-04-01 | Du Pont Merck Pharma | PROCESS AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET GLYCOPROTEIN INHIBITORS II B / III A. |
| US5879657A (en) * | 1993-03-30 | 1999-03-09 | The Dupont Merck Pharmaceutical Company | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| AP1390A (en) * | 1996-11-27 | 2005-04-15 | Aventis Pharmaceuticals Products Inc | Pharmaceutical composition comprising a compound having anti-Xa activity and a platelet aggregation antagonist compound. |
| US6010911A (en) * | 1997-04-30 | 2000-01-04 | Medtronic, Inc. | Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique |
| US6537520B1 (en) | 1998-03-31 | 2003-03-25 | Bristol-Myers Squibb Pharma Company | Pharmaceuticals for the imaging of angiogenic disorders |
| GB0623607D0 (en) | 2006-11-27 | 2007-01-03 | Haemostatix Ltd | Tissue adhesive |
| PL2118123T3 (en) | 2007-01-31 | 2016-06-30 | Dana Farber Cancer Inst Inc | Stabilized p53 peptides and uses thereof |
| KR101525754B1 (en) | 2007-03-28 | 2015-06-09 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | Stitched polypeptides |
| ES2730927T3 (en) | 2009-11-10 | 2019-11-13 | Allegro Pharmaceuticals Llc | Compositions and methods to inhibit cell adhesion or direct diagnostic or therapeutic agents to GDD binding sites |
| US11673914B2 (en) | 2009-11-10 | 2023-06-13 | Allegro Pharmaceuticals, LLC | Peptide therapies for reduction of macular thickening |
| CA2807685C (en) | 2010-08-13 | 2020-10-06 | Aileron Therapeutics, Inc. | P53 derived peptidomimetic macrocycle |
| ES2820855T3 (en) | 2011-05-09 | 2021-04-22 | Allegro Pharmaceuticals Llc | Integrin receptor antagonists and their methods of use |
| TW201806968A (en) | 2011-10-18 | 2018-03-01 | 艾利倫治療公司 | Peptidomimetic macrocycles |
| BR112014020103A2 (en) | 2012-02-15 | 2018-10-09 | Aileron Therapeutics, Inc. | peptidomimetic macrocycles |
| CA2864120A1 (en) | 2012-02-15 | 2013-08-22 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
| KR20150082307A (en) | 2012-11-01 | 2015-07-15 | 에일러론 테라퓨틱스 인코포레이티드 | Disubstituted amino acids and methods of preparation and use thereof |
| SG10201902598VA (en) | 2014-09-24 | 2019-04-29 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and formulations thereof |
| MX2017003797A (en) | 2014-09-24 | 2017-06-15 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and uses thereof. |
| US10253067B2 (en) | 2015-03-20 | 2019-04-09 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| CN108368161A (en) | 2015-09-10 | 2018-08-03 | 艾瑞朗医疗公司 | Peptidomimetic macrocyclic compound as MCL-1 conditioning agents |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2636066B1 (en) * | 1988-09-02 | 1991-10-25 | Centre Nat Rech Scient | CYCLOPEPTIDE DERIVATIVES FOR USE AS SELECTIVE INHIBITORS AGAINST ACTIVE SERINE PROTEASES |
| US5384309A (en) * | 1989-07-17 | 1995-01-24 | Genentech, Inc. | Cyclized peptides and their use as platelet aggregation inhibitors |
| AU6470590A (en) * | 1989-10-23 | 1991-04-26 | Smithkline Beecham Corporation | Cyclic anti-aggregatory peptides |
| IL103252A (en) * | 1991-09-30 | 1997-03-18 | Du Pont Merck Pharma | CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
-
1994
- 1994-03-28 AU AU64158/94A patent/AU6415894A/en not_active Abandoned
- 1994-03-28 FI FI954556A patent/FI954556A0/en unknown
- 1994-03-28 PL PL94310896A patent/PL310896A1/en unknown
- 1994-03-28 WO PCT/US1994/003223 patent/WO1994022910A1/en not_active Ceased
- 1994-03-28 CA CA002159070A patent/CA2159070A1/en not_active Abandoned
- 1994-03-28 HU HU9502832A patent/HUT72896A/en unknown
- 1994-03-28 JP JP6522195A patent/JPH08508498A/en not_active Ceased
- 1994-03-28 EP EP94911703A patent/EP0691987A1/en not_active Withdrawn
- 1994-03-28 NZ NZ263456A patent/NZ263456A/en not_active IP Right Cessation
-
1995
- 1995-09-28 NO NO953832A patent/NO953832L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2159070A1 (en) | 1994-10-13 |
| FI954556L (en) | 1995-09-26 |
| NO953832D0 (en) | 1995-09-28 |
| EP0691987A1 (en) | 1996-01-17 |
| NO953832L (en) | 1995-11-28 |
| FI954556A7 (en) | 1995-09-26 |
| AU6415894A (en) | 1994-10-24 |
| FI954556A0 (en) | 1995-09-26 |
| HUT72896A (en) | 1996-06-28 |
| HU9502832D0 (en) | 1995-11-28 |
| NZ263456A (en) | 1996-11-26 |
| JPH08508498A (en) | 1996-09-10 |
| WO1994022910A1 (en) | 1994-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL310896A1 (en) | Cyclic compounds useful as platelet iib/iiia glycoprotein inhibitors | |
| FI943478A7 (en) | Glycoprotein IIb/IIIa antagonists | |
| FI941457L (en) | Cyclic compounds useful as inhibitors of platelet glycoprotein IIb/IIIa | |
| ZA93550B (en) | Azabricyclic compounds as calcium channel antagonists | |
| AU3364493A (en) | Compounds as calcium channel antagonists | |
| GB9420114D0 (en) | Substituted cyclic derivatives as novel antidegenerative agents | |
| EP0574494A4 (en) | Indoles useful as platelet activating factor antagonists | |
| GB9317967D0 (en) | Improvements relating to plasics articles | |
| ITMI932056A1 (en) | LOCK FOR CONTAINERS SUCH AS BAGS OR SIMILAR | |
| SG44770A1 (en) | Cyclic compounds | |
| GB9311870D0 (en) | Ties | |
| ZA927515B (en) | Cyclic compounds useful as inhibitors of platelet glycoprotein IIb/IIIa | |
| GB9302261D0 (en) | Improvements relating to packaging | |
| HUT70277A (en) | New packaging/containerization system | |
| HUT66649A (en) | Containerization packaging system | |
| HUT70279A (en) | New packaging containerization system | |
| GB2257958B (en) | Improvements relating to packaging | |
| GB9312411D0 (en) | Stabilisers for cycles | |
| GB2280658B (en) | Improvements relating to containers | |
| GB9302651D0 (en) | Improvements relating to containers | |
| ITAR920017A0 (en) | COMPOSITE BOX FOR SEEDLING CONTAINERS | |
| GB9321861D0 (en) | Platelet derived growth factor analogues | |
| GB9318547D0 (en) | Improvements relating to packaging containers | |
| GB9318882D0 (en) | Improvements relating to containers | |
| GB9305150D0 (en) | Improvements relating to containers |